Predictors of survival among pediatric and adult ependymoma cases: A study using surveillance, epidemiology, and end results data from 1973 to 2007

Neuroepidemiology

Volumn 39, Issue 2, 2012, Pages 116-124

  Amirian, E Susan ^a   Armstrong, Terri S ^b   Aldape, Kenneth D ^c   Gilbert, Mark R ^d   Scheurer, Michael E ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c Departments of Pathology   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Brain cancer; Brain tumor; Ependymoma; SEER program; Survival analyses

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BRAIN TUMOR; CHILD; EPENDYMOMA; EPIDEMIC; FEMALE; HUMAN; MALE; MORTALITY; PROGNOSIS; RISK ASSESSMENT; SPINAL CORD; SPINAL CORD TUMOR; SURVIVAL; TREATMENT INDICATION; TUMOR LOCALIZATION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; EPENDYMOMA; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; SEER PROGRAM; SEX FACTORS; SPINAL CORD NEOPLASMS; SURVIVAL ANALYSIS;

EID: 84864212960     PISSN: 02515350     EISSN: 14230208     Source Type: Journal    
DOI: 10.1159/000339320     Document Type: Article

References (22)

1. Gurney JG, Smith MA, Bunin GR: CNS and miscellaneous intracranial and intraspinal neoplasms. SEER Pediatr Monogr 1995. http://seer.cancer.gov/ publications/childhood/ cns.pdf. Accessed on 5-4-2011.
2. Reni M, Gatta G, Mazza E, Vecht C: Ependymoma. Crit Rev Oncol Hematol 2007; 63: 81- 89.
3. McCarthy BJ, Dolecek TA, Danciu OC, Villano JL: Descriptive epidemiology of ependymal tumors in the United States (abstract). J Clin Oncol 2010; 28:e12524.
4. McGuire CS, Sainani KL, Fisher PG: Incidence patterns for ependymoma: A surveillance, epidemiology, and end results study. J Neurosurg 2009; 110: 725-729.
5. Korshunov A, Golanov A, Sycheva R, Timirgaz V: The histologic grade is a main prognostic factor for patients with intracranial ependymomas treated in the microneurosurgical era: An analysis of 258 patients. Cancer 2004; 100: 1230-1237.
6. Armstrong TS, Vera-Bolanos E, Bekele BN, Aldape K, Gilbert MR: Adult ependymal tumors: Prognosis and the M. D. Anderson Cancer Center experience. Neuro Oncol 2010; 12: 862-870.
7. Gilbert MR, Ruda R, Soffietti R: Ependymomas in adults. Curr Neurol Neurosci Rep 2010; 10: 240-247.
8. Weber DC, Zilli T, Do HP, Nouet P, Gumy Pause F, Pica A: Intensity modulated radiation therapy or stereotactic fractionated radiotherapy for infratentorial ependymoma in children: A multicentric study. J Neurooncol 2011; 102: 295-300.
9. McGuire CS, Sainani KL, Fisher PG: Both location and age predict survival in ependymoma: A SEER study. Pediatr Blood Cancer 2009; 52: 65-69.
10. Metellus P, Guyotat J, Chinot O, Durand A, Barrie M, Giorgi R, Jouvet A, Figarella- Branger D: Adult intracranial WHO grade II ependymomas: Long-term outcome and prognostic factor analysis in a series of 114 patients. Neuro Oncol 2010; 12: 976-984.
11. Gupta N, Banerjee A, Haas-Kogan D: Pediatric CNS Tumors, ed 2. Berlin, Springer, 2010.
12. Metellus P, Barrie M, Figarella-Branger D, Chinot O, Giorgi R, Gouvernet J, Jouvet A, Guyotat J: Multicentric French study on adult intracranial ependymomas: Prognostic factors analysis and therapeutic considerations from a cohort of 152 patients. Brain 2007; 130: 1338-1349.
13. Rodriguez D, Cheung MC, Housri N, Quinones- Hinojosa A, Camphausen K, Koniaris LG: Outcomes of malignant CNS ependymomas: An examination of 2,408 cases through the Surveillance, Epidemiology, and End Results (SEER) database (1973-2005). J Surg Res 2009; 156: 340-351.
14. McLaughlin MP, Marcus RB Jr, Buatti JM, McCollough WM, Mickle JP, Kedar A, Maria BL, Million RR: Ependymoma: Results, prognostic factors and treatment recommendations. Int J Radiat Oncol Biol Phys 1998; 40: 845-850.
15. Reni M, Brandes AA, Vavassori V, Cavallo G, Casagrande F, Vastola F, Magli A, Franzin A, Basso U, Villa E: A multicenter study of the prognosis and treatment of adult brain ependymal tumors. Cancer 2004; 100: 1221-1229.
16. LeBlanc M, Crowley J: Relative risk trees for censored survival data. Biometrics 1992; 48: 411-425.
17. Lemon SC, Roy J, Clark MA, Friedmann PD, Rakowski W: Classification and regression tree analysis in public health: Methodological review and comparison with logistic regression. Ann Behav Med 2003; 26: 172-181.
18. Segal M: Regression trees for censored data. Biometrics 1988; 44: 35-47.
19. van Putten W: CART: Stata module to perform classification and regression tree analysis. Statistical Software Components. Boston College Department of Economics, 2006. http://econpapers.repec.org RePEc:boc: Bocode:s456776. Accessed on 12-15-2010.
20. Tamburrini G, D'Ercole M, Pettorini BL, Caldarelli M, Massimi L, Di Rocco C: Survival following treatment for intracranial ependymoma: A review. Childs Nerv Syst 2009; 25: 1303-1312.
21. Rousseau P, Habrand JL, Sarrazin D, Kalifa C, Terrier-Lacombe MJ, Rekacewicz C, Rey A: Treatment of intracranial ependymomas of children: Review of a 15-year experience. Int J Radiat Oncol Biol Phys 1994; 28: 381- 386.
22. Koshy M, Rich S, Merchant TE, Mahmood U, Regine WF, Kwok Y: Post-operative radiation improves survival in children younger than 3 years with intracranial ependyependymoma. J Neurooncol 2011; 105: 583-590.